RT Journal Article
SR Electronic
T1 CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 101
DO 10.1186/s40425-019-0575-3
VO 7
IS 1
A1 Gonzalez-Exposito, Reyes
A1 Semiannikova, Maria
A1 Griffiths, Beatrice
A1 Khan, Khurum
A1 Barber, Louise J.
A1 Woolston, Andrew
A1 Spain, Georgia
A1 von Loga, Katharina
A1 Challoner, Ben
A1 Patel, Radhika
A1 Ranes, Michael
A1 Swain, Amanda
A1 Thomas, Janet
A1 Bryant, Annette
A1 Saffery, Claire
A1 Fotiadis, Nicos
A1 Guettler, Sebastian
A1 Mansfield, David
A1 Melcher, Alan
A1 Powles, Thomas
A1 Rao, Sheela
A1 Watkins, David
A1 Chau, Ian
A1 Matthews, Nik
A1 Wallberg, Fredrik
A1 Starling, Naureen
A1 Cunningham, David
A1 Gerlinger, Marco
YR 2019
UL http://jitc.bmj.com/content/7/1/101.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.